Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Longevity Group Co. Ltd. ( (HK:1863) ) just unveiled an announcement.
China Longevity Group has provided an operational update, stating that its production, operations, and finances remain healthy while it continues to focus on research and development of new materials and products. This suggests the business itself is functioning steadily despite the prolonged suspension of trading in its shares.
The company’s shares have been suspended from trading on the Hong Kong Stock Exchange since February 2013, but the bourse has so far withheld exercising its right to delist the stock, and the company has not received any delisting notice. Regulatory concerns raised by the Securities and Futures Commission remain unresolved, with the Commission’s board having repeatedly adjourned consideration of the firm’s resumption application and possibly seeking further information, leaving shareholders facing continued uncertainty over the timing and outcome of any trading resumption.
More about China Longevity Group Co. Ltd.
China Longevity Group Company Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates through subsidiaries with a focus on production and research and development of new materials and products. The Group reports that its production, operations, and financial position remain healthy as it continues to prioritise innovation in its materials portfolio and product pipeline.
Learn more about 1863 stock on TipRanks’ Stock Analysis page.